The CD4+ T cells are able to eliminate tumors resistant to CD8+ T cell-mediated rejection, while the successful anticancer effect leading to tumor rejection is mediated by cooperation between CD8+ and CD4+ T cells [11,12]. Here, CD8A is linked to neoplasm.